Jul 23, 2026 03:24AM
Jul 21, 2026 05:09AM
Jul 3, 2026 03:03AM
Jul 1, 2026 04:35PM
Jul 1, 2026 06:22AM
Jun 25, 2026 06:48AM
Jun 25, 2026 03:00AM Buy this biotech stock on weakness: Barclays
Jun 24, 2026 09:45AM
Jun 24, 2026 09:37AM
Jun 24, 2026 06:30AM
Jun 24, 2026 04:12AM
Jun 4, 2026 06:40AM
May 28, 2026 04:07PM
May 8, 2026 06:33AM RBC Capital Reiterates Outperform Rating on argenx SE (ARGX), 'We Would Remain Buyers Ahead of Busy Calendar"
May 7, 2026 06:12AM
May 6, 2026 04:02PM
Apr 19, 2026 10:00AM
Apr 16, 2026 01:00AM
Apr 14, 2026 09:08AM
Apr 1, 2026 06:00AM
Mar 16, 2026 05:27PM argenx SE (ARGX) PT Raised to $1,013 at Jefferies
Mar 13, 2026 09:32AM
Mar 11, 2026 03:55AM
Mar 10, 2026 04:03PM
Feb 27, 2026 02:20PM
Feb 27, 2026 04:25AM
Feb 26, 2026 12:20PM
Feb 26, 2026 11:52AM argenx SE (ARGX) PT Lowered to $1,227 at Stifel
Feb 26, 2026 02:49AM
Jan 12, 2026 01:21PM
Jan 8, 2026 08:49AM
Jan 6, 2026 06:43AM
Jan 5, 2026 10:15AM
Dec 22, 2025 07:06AM
Dec 18, 2025 06:24AM BofA: 'Top SMid Biotech Picks Argenx, KalVista, Ocular, and Vertex'
Dec 18, 2025 06:17AM
Dec 18, 2025 02:49AM
Dec 17, 2025 07:38AM
Dec 15, 2025 01:32PM
Dec 15, 2025 10:25AM
Dec 15, 2025 10:24AM
Dec 15, 2025 06:56AM argenx discontinues thyroid eye disease studies after futility analysis
Dec 11, 2025 07:46AM
Dec 9, 2025 06:23AM
Nov 24, 2025 02:30PM
Nov 24, 2025 05:32AM
Nov 19, 2025 08:29AM
Nov 17, 2025 05:23AM
Nov 4, 2025 08:24AM 'argenx SE (ARGX) Remains a Top Pick'; PT Raised to $930 at Piper Sandler
Oct 31, 2025 09:19AM

433,962 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All